249 related articles for article (PubMed ID: 11956238)
1. The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model.
Semsarian C; Ahmad I; Giewat M; Georgakopoulos D; Schmitt JP; McConnell BK; Reiken S; Mende U; Marks AR; Kass DA; Seidman CE; Seidman JG
J Clin Invest; 2002 Apr; 109(8):1013-20. PubMed ID: 11956238
[TBL] [Abstract][Full Text] [Related]
2. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
[TBL] [Abstract][Full Text] [Related]
3. A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy.
Semsarian C; Healey MJ; Fatkin D; Giewat M; Duffy C; Seidman CE; Seidman JG
J Mol Cell Cardiol; 2001 Nov; 33(11):2055-60. PubMed ID: 11708849
[TBL] [Abstract][Full Text] [Related]
4. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.
Tsoutsman T; Kelly M; Ng DC; Tan JE; Tu E; Lam L; Bogoyevitch MA; Seidman CE; Seidman JG; Semsarian C
Circulation; 2008 Apr; 117(14):1820-31. PubMed ID: 18362229
[TBL] [Abstract][Full Text] [Related]
5. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
[TBL] [Abstract][Full Text] [Related]
6. A novel beta-myosin heavy chain gene mutation, p.Met531Arg, identified in isolated left ventricular non-compaction in humans, results in left ventricular hypertrophy that progresses to dilation in a mouse model.
Kaneda T; Naruse C; Kawashima A; Fujino N; Oshima T; Namura M; Nunoda S; Mori S; Konno T; Ino H; Yamagishi M; Asano M
Clin Sci (Lond); 2008 Mar; 114(6):431-40. PubMed ID: 17956225
[TBL] [Abstract][Full Text] [Related]
7. An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy.
Fatkin D; McConnell BK; Mudd JO; Semsarian C; Moskowitz IG; Schoen FJ; Giewat M; Seidman CE; Seidman JG
J Clin Invest; 2000 Dec; 106(11):1351-9. PubMed ID: 11104788
[TBL] [Abstract][Full Text] [Related]
8. The pathogenesis of familial hypertrophic cardiomyopathy: early and evolving effects from an alpha-cardiac myosin heavy chain missense mutation.
Georgakopoulos D; Christe ME; Giewat M; Seidman CM; Seidman JG; Kass DA
Nat Med; 1999 Mar; 5(3):327-30. PubMed ID: 10086390
[TBL] [Abstract][Full Text] [Related]
9. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
[TBL] [Abstract][Full Text] [Related]
10. Beta-myosin heavy chain gene mutations in familial hypertrophic cardiomyopathy: the usual suspect?
McNally EM
Circ Res; 2002 Feb; 90(3):246-7. PubMed ID: 11861410
[No Abstract] [Full Text] [Related]
11. Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy.
Chiu C; Tebo M; Ingles J; Yeates L; Arthur JW; Lind JM; Semsarian C
J Mol Cell Cardiol; 2007 Sep; 43(3):337-43. PubMed ID: 17655857
[TBL] [Abstract][Full Text] [Related]
12. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
Ramírez CD; Padrón R
Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
[TBL] [Abstract][Full Text] [Related]
13. Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy.
Westermann D; Knollmann BC; Steendijk P; Rutschow S; Riad A; Pauschinger M; Potter JD; Schultheiss HP; Tschöpe C
Eur J Heart Fail; 2006 Mar; 8(2):115-21. PubMed ID: 16214409
[TBL] [Abstract][Full Text] [Related]
14. Sarcoplasmic reticulum calcium overloading in junctin deficiency enhances cardiac contractility but increases ventricular automaticity.
Yuan Q; Fan GC; Dong M; Altschafl B; Diwan A; Ren X; Hahn HH; Zhao W; Waggoner JR; Jones LR; Jones WK; Bers DM; Dorn GW; Wang HS; Valdivia HH; Chu G; Kranias EG
Circulation; 2007 Jan; 115(3):300-9. PubMed ID: 17224479
[TBL] [Abstract][Full Text] [Related]
15. Cardiac and skeletal muscle expression of mutant β-myosin heavy chains, degree of functional impairment and phenotypic heterogeneity in hypertrophic cardiomyopathy.
Di Domenico M; Casadonte R; Ricci P; Santini M; Frati G; Rizzo A; Carratelli CR; Lamberti M; Parrotta E; Quaresima B; Faniello CM; Costanzo F; Cuda G
J Cell Physiol; 2012 Oct; 227(10):3471-6. PubMed ID: 22213221
[TBL] [Abstract][Full Text] [Related]
16. Mutation of Arg723Gly in beta-myosin heavy chain gene in five Chinese families with hypertrophic cardiomyopathy.
Yang JH; Zheng DD; Dong NZ; Yang XJ; Song JP; Jiang TB; Cheng XJ; Li HX; Zhou BY; Zhao CM; Jiang WP
Chin Med J (Engl); 2006 Nov; 119(21):1785-9. PubMed ID: 17097032
[TBL] [Abstract][Full Text] [Related]
17. Disease-modifying mutations in familial hypertrophic cardiomyopathy: complexity from simplicity.
Hilfiker-Kleiner D; Knöll R
Circulation; 2008 Apr; 117(14):1775-7. PubMed ID: 18391120
[No Abstract] [Full Text] [Related]
18. Familial hypertrophic cardiomyopathy: functional effects of myosin mutation R723G in cardiomyocytes.
Kraft T; Witjas-Paalberends ER; Boontje NM; Tripathi S; Brandis A; Montag J; Hodgkinson JL; Francino A; Navarro-Lopez F; Brenner B; Stienen GJ; van der Velden J
J Mol Cell Cardiol; 2013 Apr; 57():13-22. PubMed ID: 23318932
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of junctin causes adaptive changes in cardiac myocyte Ca(2+) signaling.
Kirchhefer U; Hanske G; Jones LR; Justus I; Kaestner L; Lipp P; Schmitz W; Neumann J
Cell Calcium; 2006 Feb; 39(2):131-42. PubMed ID: 16289269
[TBL] [Abstract][Full Text] [Related]
20. Sarcomere protein gene mutations and inherited heart disease: a beta-cardiac myosin heavy chain mutation causing endocardial fibroelastosis and heart failure.
Kamisago M; Schmitt JP; McNamara D; Seidman C; Seidman JG
Novartis Found Symp; 2006; 274():176-89; discussion 189-95, 272-6. PubMed ID: 17019812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
